Skip to content

Environmental Health Perspectives

Facebook Page EHP Twitter Feed Open Access icon  

Erratum November 2017 | Volume 125 | Issue 11

Email this to someoneShare on FacebookTweet about this on TwitterShare on LinkedInShare on Google+Share on StumbleUpon
Environ Health Perspect; DOI:10.1289/EHP2784

Erratum: “Urinary Concentrations of Organophosphate Flame Retardant Metabolites and Pregnancy Outcomes among Women Undergoing in Vitro Fertilization”

Courtney C. Carignan, Lidia Mínguez-Alarcón, Craig M. Butt, Paige L. Williams, John D. Meeker, Heather M. Stapleton, Thomas L. Toth, Jennifer B. Ford, and Russ Hauser, for the EARTH Study Team

PDF icon PDF Version (233 KB)

  • Received: 1 September 2017
    Accepted: 9 September 2017
    Published: 1 November 2017

    Address correspondence to C. Carignan, Department of Environmental Health, Building 1, 14th Floor, 665 Huntington Avenue, Boston, MA 02115 USA. Phone: (617) 432-4572. Email: carignan@hsph.harvard.edu

    Note to readers with disabilities: EHP strives to ensure that all journal content is accessible to all readers. However, some figures and Supplemental Material published in EHP articles may not conform to 508 standards due to the complexity of the information being presented. If you need assistance accessing journal content, please contact ehponline@niehs.nih.gov. Our staff will work with you to assess and meet your accessibility needs within 3 working days.

Related EHP Article

Urinary Concentrations of Organophosphate Flame Retardant Metabolites and Pregnancy Outcomes among Women Undergoing in Vitro Fertilization

Courtney C. Carignan, Lidia Mínguez-Alarcón, Craig M. Butt, Paige L. Williams, John D. Meeker, Heather M. Stapleton, Thomas L. Toth, Jennifer B. Ford, Russ Hauser, for the EARTH Study Team

Carignan et al. have noted an error in Figure 2 of their paper, “Urinary Concentrations of Organophosphate Flame Retardant Metabolites and Pregnancy Outcomes among Women Undergoing in Vitro Fertilization.” The correct figure is included in this erratum and was part of the original submission, peer review, and accepted article. The error occurred when the authors responded to a proof request for a formatting edit, and a mistake was made in recreating the bottom row of the figure. The authors regret the error.

 

 

First set of four plots showing changes in the mean proportion of cycles resulting in implantation (y-axis) across gamma PFR, BDCIPP, DPHP, and ip-PPP in Q1, Q2, Q3, and Q4 (x-axis; respective p trend values are 0.02, 0.06, 0.02, and 0.05). Second set of four plots showing changes in mean proportion of cycles resulting in clinical pregnancy (y-axis) across the above-mentioned organophosphate flame retardant metabolite concentrations in the four quartiles (x-axis; respective p trend values are 0.004, 0.07, 0.01, and 0.19). Third set of four plots showing changes in mean proportion of cycles resulting in live birth (y-axis) across the above-mentioned organophosphate flame retardant metabolite concentrations in the four quartiles (x-axis; respective p trend values are 0.05, 0.16, 0.08, and 0.04).
Figure 2. Adjusted mean [95% confidence interval (CI)] proportion of cycles resulting in implantation, live birth, and clinical pregnancy by quartile of urinary organophosphate flame retardant (PFR) metabolite concentrations among 211 women undergoing 297 in vitro fertilization (IVF) cycles. Gray shading indicates change in means from the first and fourth quartile. Adjusted models control for maternal age (continuous), body mass index (BMI) (continuous), race/ethnicity (black/Asian/other, white/Caucasian), year of IVF treatment cycle (continuous), and primary Society for Assisted Reproductive Technology (SART) infertility diagnosis at study entry (female, male, unknown), with continuous variables at their mean level and categorical variables weighted by their frequency in the study population. *Significantly different from the lowest quartile (Q1) at the α = 0.05 level.

WP-Backgrounds Lite by InoPlugs Web Design and Juwelier Schönmann 1010 Wien